Following the first hypothesis, adiponectin regulation might represent a metabolic response in bronchiectasis-COPD patients that very often undergo a fat-free mass depletion [22] rather than a response to pulmonary function decline. The gene discussed is ADIPOQ; the disease is bronchiectasis.